Gabapentin, an anticonvulsant and nerve ache treatment, isn’t sometimes included in customary drug screenings. Routine urine drug checks primarily detect substances like opioids, benzodiazepines, amphetamines, cocaine, and marijuana. The presence of gabapentin requires particular testing strategies past these customary panels.
The rare inclusion of gabapentin in drug screenings stems from its comparatively low potential for abuse in comparison with different managed substances. Testing for this treatment is normally solely carried out when there’s a particular medical indication or suspicion of misuse, reminiscent of in circumstances of suspected drug diversion or in sufferers with a historical past of substance abuse. Its detection provides insights into treatment adherence or potential off-label use.